Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic

FOXO4-DRI
FOXO4-DRI
$268.00 Buy Now

FOXO4-DRI

$268.00

Research-grade FOXO4-DRI (FOXO4-D-Retro-Inverso) is a synthetic D-retro-inverso octapeptide (Arg-R-Arg-R-Gln-R-Arg-R-Arg), designed for controlled investigations of FOXO4-p53 disruption, selective clearance of senescent cells, apoptosis induction, and age-related tissue rejuvenation.

In stock

Free shipping on all orders over $200 (US)

  • 99% Purity – Third-Party Tested
  • Fast & Reliable Shipping
Guaranteed Safe Checkout

FOXO4-DRI is a groundbreaking D-amino acid retro-inverso peptide developed by Peter de Keizer’s group at Erasmus MC. It selectively disrupts the FOXO4-p53 interaction that protects senescent cells from apoptosis, inducing their targeted clearance while sparing healthy cells. First published in 2017, it demonstrated dramatic lifespan extension and tissue rejuvenation in progeroid and naturally aged mice. This research-grade lyophilized peptide is synthesized under strict quality controls and provided with full analytical documentation, making it the gold-standard tool for senolytics, longevity, and age-related disease research.

Key Scientific

  • High-purity FOXO4-DRI (≥ 99% by HPLC/MS, TFA salt form)
  • Verified D-retro-inverso octapeptide sequence: D-Arg-D-Arg-D-Gln-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg
  • Lyophilized formulation for maximum long-term stability
  • Full Certificate of Analysis (COA) with HPLC, MS, amino acid analysis, and in vitro p53-binding disruption assay
  • Manufactured in GMP-aligned, ISO-compliant facilities
  • Ideal for senescent cell clearance, FOXO4-p53 interaction, and anti-aging studies

Research-Referenced Attributes (Based on scientific literature; not intended as therapeutic claims.)

  • Selectively disrupts FOXO4-p53 nuclear retention → targeted apoptosis of senescent cells (senolytics)
  • Dramatically extends lifespan in progeroid mice (up to 30%) and rejuvenates tissues in naturally aged animals
  • Reduces senescent cell burden in liver, kidney, and muscle without affecting healthy cells
  • Improves physical function, fur density, and wound healing in aged mice
  • No genotoxicity or off-target effects in preclinical safety studies
  • Valuable in progeria, sarcopenia, fibrosis, and age-related degenerative disease research

Why Researchers Choose Nationwide Peptides FOXO4-DRI

  • Exact D-retro-inverso sequence used in the original Erasmus MC discovery studies
  • Highest documented senolytic potency and selectivity among research suppliers
  • Transparent analytical data (HPLC >99%, MS confirmation of D-amino acids)
  • Trusted by longevity, senolytics, and regenerative medicine laboratories worldwide
  • Competitive research pricing with bulk options

Storage & Handling

  • Store lyophilized powder at –4 °F (long-term) or 39.2 °F (short-term)
  • Store in a tightly sealed container and protect from light, moisture, air exposure, and elevated temperatures.
  • Reconstitute only with sterile water or saline (typical concentration 1–5 mg/mL)
  • Reconstituted solutions stable at 39.2 °F for up to 4 weeks; avoid repeated freeze-thaw cycles
  • Use appropriate PPE and aseptic technique

Peptide Research